Zhonghong Pulin Medical Products Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jun Chen

Chief executive officer

CN¥658.3k

Total compensation

CEO salary percentage	n/a
CEO tenure	2.3yrs
CEO ownership	0.001%
Management average tenure	no data
Board average tenure	2.1yrs

Recent management updates

Recent updates

There Is A Reason Zhonghong Pulin Medical Products Co., Ltd.'s (SZSE:300981) Price Is Undemanding

Mar 21

CEO

Jun Chen (43 yo)

2.3yrs

Tenure

CN¥658,300

Compensation

Mr. Jun Chen is General Manager of Zhonghong Pulin Medical Products Co., Ltd. since January 07, 2022.

Board Members

Name	Position	Tenure	Compensation	Ownership
Shujun Sang	Chairman of the Board	12.3yrs	no data	11.14% CN¥ 523.9m
Yuan Zeng	Non-Independent Director	2.1yrs	no data	no data
Xudong Zhang	Independent Director	2.1yrs	CN¥60.00k	no data
Yi Su	Non-Independent Director	1.2yrs	no data	no data
Zhidong Zhan	Non-Independent Director	1.2yrs	no data	no data

2.1yrs

Average Tenure

49yo

Average Age

Experienced Board: 300981's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.

Zhonghong Pulin Medical Products Management

Management criteria checks 1/4

Key information

Recent management updates

Zhonghong Pulin Medical Products Co., Ltd., Annual General Meeting, May 16, 2024

High number of new and inexperienced directors

High number of new directors

High number of new and inexperienced directors

Zhonghong Pulin Medical Products Co., Ltd. Approves Board Elections

Recent updates

Zhonghong Pulin Medical Products Co., Ltd. Proposes Final Cash Dividend for the Year 2023

Zhonghong Pulin Medical Products Co., Ltd., Annual General Meeting, May 16, 2024

Full year 2023 earnings released: CN¥0.34 loss per share (vs CN¥0.17 profit in FY 2022)

Zhonghong Pulin Medical Products Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

There Is A Reason Zhonghong Pulin Medical Products Co., Ltd.'s (SZSE:300981) Price Is Undemanding

New minor risk - Share price stability

Zhonghong Pulin Medical Products Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.036 (vs CN¥0.089 loss in 3Q 2022)

Zhonghong Pulin Medical Products Co., Ltd. (SZSE:300981) commences an Equity Buyback Plan for 877,888 shares, representing 0.23% for CNY 13.3 million, under the authorization approved on September 27, 2023.

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: CN¥0.003 (vs CN¥0.03 in 2Q 2022)

Zhonghong Pulin Medical Products Co., Ltd. Announces Final Dividend for 2022, Payable on 26 May 2023

Zhonghong Pulin Medical Products Co., Ltd. Approves Final Cash Dividend for the Year 2022

First quarter 2023 earnings released: CN¥0.02 loss per share (vs CN¥0.21 profit in 1Q 2022)

High number of new and inexperienced directors

Zhonghong Pulin Medical Products Co., Ltd. (SZSE:300981) signed Share Purchase Agreement to acquire 70% in Guilin HBM Health Protections, Inc. from group of shareholders for CNY 541 million.

Third quarter 2022 earnings released: CN¥0.12 loss per share (vs CN¥0.78 profit in 3Q 2021)

Now 24% undervalued after recent price drop

Now 21% undervalued after recent price drop

High number of new directors

Zhonghong Pulin Medical Products Co., Ltd. Announces Cash Dividend, Payable on May 30, 2022

Zhonghong Pulin Medical Products Co., Ltd. Announces Cash Dividend, Payable on May 30, 2022

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS: CN¥0.37 (vs CN¥11.22 in 1Q 2021)

Now 33% undervalued after recent price drop

High number of new and inexperienced directors

Zhonghong Pulin Medical Products Co., Ltd. Approves Board Elections

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥1.41 (vs CN¥8.81 in 3Q 2020)

Investor sentiment deteriorated over the past week

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age